BIO 2020

Kura Oncology CEO Troy Wilson

Biotech

Kura Oncology CEO Wilson on the quest beyond KRAS

Troy Wilson’s Wellspring Biosciences was working on a KRAS drug with J&J when a thought struck him: Are there other ways to tackle the same pathway?

Amirah Al Idrus Jun 12, 2020 7:00am

Audentes Therapeutics CEO Natalie Holles

BIO: Audentes CEO Holles on keeping the biotech spirit

Jun 11, 2020 10:50am

BridgeBio Pharma CEO and founder Neil Kumar

CEO Kumar on BridgeBio's model and where else it could work

Jun 10, 2020 8:40am

Boehringer Ingelheim global head of BD and licensing Ioannis Sapountzis

Boehringer BD head Sapountzis on striking deals during COVID-19

Jun 9, 2020 3:00pm

Orchard Therapeutics CEO Bobby Gaspar

BIO: Orchard CEO Gaspar on the company's 2020 pivot

Jun 9, 2020 10:45am

Nimbus Therapeutics CEO Jeb Keiper and Chief Scientific Officer Peter Tummino

BIO: Nimbus CEO Keiper: 'We're not just a one-hit wonder'

Jun 8, 2020 8:00am